An early-stage gold exploration company is strategically positioned for success and fully funded for its 2020 exploration activities.
Silver Now Setting The Pace In Precious Metals: What This Means For Investors
Silver is up over 20% in the last week. That's great news for silver investors. It's also great news for gold investors.
Buy Gold Mining Stocks: Why Ounces-In-The-Ground Is Today’s Best Investment
Gold mining stocks offer the best risk/reward proposition and most upside potential of any class of equities.
Stand and Deliver! Is The Great Big-Bank Bullion Robbery Finally Over?
Craig Hemke of TF Metals makes a powerful case that the days of the Big Banks bullying precious metals markets are coming to an end.
Epic Rally in Gold Mining Stocks Now Confirmed
The price of gold has just broken above $1,800 per ounce. Gold mining stocks were already in full rally mode. Get ready for take-off!
Two Low-Grade/Bulk-Tonnage Gold Mining Companies To Watch
As investor focus turns toward lower grade gold projects, here are two companies worth a closer look.
Osoyoos Announces Agreement to Acquire AI Pharmaceuticals Jamaica Limited
Osoyoos Cannabis has acquired a psilocybin-focused biopharma company based in Jamaica.
Fed Folly Part 2: How The Federal Reserve Will Finish Its Destruction Of The Dollar
Part 1 explained why ALL fiat currencies go to zero. Part 2 shows HOW the Federal Reserve is completing the destruction of the dollar.
Numinus announces Clinical Advisory Council to advance its integrated wellness model
Advisors including Dr. Gabor Maté and Zach Walsh bring training and expertise in psychedelic-assisted therapy and mental health treatment.
MindMed And Eleusis Lead The Way In Psychedelics Micro-Dosing Research
Psychedelics micro-dosing R&D is currently dominated by one public company and one private company.
Fed Folly Part 1: We Already Know How This Will End, USD Goes To ZERO
All fiat currencies collapse. The Federal Reserve is about to demonstrate this in this monetary deja vu.
Champignon Announces Closing of $15 Million Bought Deal Private Placement
Champignon Brands closes on a $15 million financing to fund its clinical research on psychedelics.
